Navigation Links
China Medical Technologies Announces Selected Unaudited Preliminary Financial Results for the Fourth Fiscal Quarter and Full Year Ended March 31, 2009
Date:6/19/2009

BEIJING, June 19 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the ''Company'') (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products today announced selected unaudited preliminary financial results for the fourth fiscal quarter (''4Q FY2008'') and the full year of the fiscal year ended March 31, 2009 (''FY2008''). The Company's 2008 fiscal year ends on March 31, 2009.

    Selected Unaudited Preliminary Financial Results for 4Q FY2008
    -- Revenues from continuing operation increased by approximately 37% year-
       over-year to approximately RMB248 million (US$36 million).
    -- Non-GAAP adjusted income from continuing operation, as defined below,
       increased by approximately 43% year-over-year to approximately RMB116
       million (US$17 million).
    -- Non-GAAP adjusted diluted earnings from continuing operation per ADS*,
       as defined below, increased by approximately 44% year-over-year to
       approximately RMB4.4 (US$0.6).

    Selected Unaudited Preliminary Financial Results for FY2008
    -- Revenues from continuing operation increased by approximately 51% year-
       over-year to approximately RMB829 million (US$121 million).
    -- Non-GAAP adjusted income from continuing operation, as defined below,
       increased by approximately 79% year-over-year to approximately RMB416
       million (US$61 million).
    -- Non-GAAP adjusted diluted earnings from continuing operation per ADS*,
       as defined below, increased by approximately 80% year-over-year to
       approximately RMB15.8 (US$2.3).

    *One American Depositary Share (''ADS'') = 10 ordinary shares

The above selected numbers are preliminary in nature and are subject to change before the Company completes its financial reporting procedures. The Company expects to report its full unaudited financial results for 4Q FY2008 and FY2008 in late July 2009.

For the convenience of readers, certain RMB amounts have been translated into U.S. dollars at the rate of RMB6.8329 to US$1.00, the noon buying rate in New York City for cable transfers of RMB per U.S. dollar as set forth in the H.10 weekly statistical release of the Federal Reserve Board, as of Tuesday, March 31, 2009.

Non-GAAP Measure Disclosures

To supplement its consolidated financial statements presented in accordance with United States Generally Accepted Accounting Principles (''GAAP''), the Company uses non-GAAP measures of adjusted income from continuing operation and adjusted earnings from continuing operation per ADS, which are adjusted from results based on GAAP to exclude the impact of stock compensation expense, amortization of acquired intangible assets and acquired in-process research and development charge. Non-GAAP financial measures are used by the Company in their financial and operating decision-making because management believes they reflect the Company's ongoing business in a manner that allows meaningful period-to-period comparison. The Company's management believes that these non-GAAP financial measures provide useful information to investors and others in understanding and evaluating the Company's current operating performance and future prospects in the same manner as management does, if they so choose. The Company's management also believes the non-GAAP financial measures are useful for itself and investors because it makes more meaningful comparisons of the Company's current results of operations to those of prior periods.

About China Medical Technologies, Inc.

China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders. For more information, please visit http://www.chinameditech.com .

    For more information, please contact:

     Winnie Yam
     Tel:   +852-2511-9808
     Email: IR@chinameditech.com

'/>"/>
SOURCE China Medical Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Jiangbo Pharmaceuticals to Attend the 44th China New Drugs Trade Fair in Tianjin
2. NYSE Amex Accepts China Shenghuos Compliance Plan for Continued Listing
3. BMP Sunstone to be Featured on SIGs China Healthcare On Call Conference Call Series
4. China Sky One Medical, Inc. Obtains SFDA Approval for Diclofenac Sodium Eye Drops
5. China Nepstar Chain Drugstore Appoints Chief Operating Officer
6. China Sky One Medical, Inc. Welcomes Commercial Counselor from Belgium; Looks for Business Alliance with European Companies
7. China Nepstar Chain Drugstore Reports First Quarter 2009 Financial Results
8. China Nepstar Chain Drugstore Filed 2008 Annual Report on Form 20-F
9. China Kangtai Cactus Biotech Announces Goal to Expand and Enhance Shareholder Communication
10. Frost & Sullivan Looks at the Influence of Chinas New Health Reform on the Pharmaceutical Market
11. NSD Bio Group, LLC Selected By U.S. - China Economic & Security Review Commission for Analysis of Chinas Pharma Supply Chain on U.S. Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the largest ... as the Medical Director of its new Mesquite-Samuell Farm facility. , “We are ... Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that ... chosen by their peers for this recognition are considered among the top 2 percent ... special honors as members of this year’s Legal Elite Hall of Fame: Miami ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Dialysis Devices Global Market - Forecast to 2022" report ... is the treatment method for the patients with kidney failure, ... and excess fluid from the patient,s blood and thus the ... sodium, potassium and chloride in balance. Increasing ...
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: